10/21
01:24 pm
vtgn
VistaGen Therapeutics (NASDAQ:VTGN) had its "outperform" rating reaffirmed by analysts at William Blair.
Low
Report
VistaGen Therapeutics (NASDAQ:VTGN) had its "outperform" rating reaffirmed by analysts at William Blair.
10/21
01:24 pm
vtgn
VistaGen Therapeutics (NASDAQ:VTGN) had its "outperform" rating reaffirmed by analysts at William Blair.
Low
Report
VistaGen Therapeutics (NASDAQ:VTGN) had its "outperform" rating reaffirmed by analysts at William Blair.